PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 17, 2003Clinical Science33 citations

ETA receptors mediate vasoconstriction, whereas ETB receptors clear endothelin-1 in the splanchnic and renal circulation of healthy men

View Full Paper
FBFelix BöhmJPJohn PernowJLJonas LINDSTRÖM

Key Result

ETA receptor blockade with BQ123 inhibited ET-1-induced increases in splanchnic (64% vs -1%, P<0.05) and renal vascular resistance, while ETB blockade increased basal resistance.

Structured PICO

Do ETA and ETB receptors mediate basal vascular tone and ET-1-induced vasoconstriction in the renal and splanchnic vasculature of healthy men?

P
Population
6 healthy men undergoing ET-1 infusion alone and in combination with ETA or ETB receptor antagonists to assess vascular tone.
I
Intervention
Infusion of endothelin-1 (ET-1) alone and in combination with the selective ETA receptor antagonist BQ123 or the selective ETB receptor antagonist BQ788 on three different occasions
C
Comparator
Control conditions (ET-1 alone or basal state)
O
Outcome
Changes in splanchnic vascular resistance (SplVR), renal vascular resistance (RVR), and plasma ET-1 levelssurrogate

In healthy men, ETA receptors mediate ET-1-induced splanchnic and renal vasoconstriction, whereas ETB receptors function as clearance receptors that modulate vascular tone by altering plasma ET-1 concentrations.

Main Result

Absolute Event Rate: -1% vs 64%

p-value: p=<0.05

Abstract

The contribution of the endothelin (ET) receptors ETA and ETB to basal vascular tone and ET-1-induced vasoconstriction in the renal and splanchnic vasculature was investigated in six healthy humans. ET-1 was infused alone and in combination with the selective ETA receptor antagonist BQ123 or the selective ETB receptor antagonist BQ788 on three different occasions. BQ123 did not affect basal arterial blood pressure, splanchnic vascular resistance (SplVR) or renal vascular resistance (RVR), but inhibited the increase in vascular resistance induced by ET-1 64±18 versus -1±7% in SplVR (P0.05); 36±6 versus 12±3% in RVR (P0.0001). BQ788 increased basal SplVR and RVR 38±16% (P = 0.01) and 21±5% (P0.0001) respectively, and potentiated the ET-1-induced vasoconstriction. Plasma ET-1 increased more after ETB blockade than under control conditions or after ETA blockade. These findings suggest that the ETA receptor mediates the splanchnic and renal vasoconstriction induced by ET-1 in healthy humans. The ETB receptor seems to function as a clearance receptor and may modulate vascular tone by altering the plasma concentration of ET-1.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Böhm et al. (2003) studied Healthy (n=6). BQ123 (ETA antagonist) and BQ788 (ETB antagonist) vs. ET-1 alone was evaluated on Increase in splanchnic vascular resistance (SplVR) induced by ET-1 (p=<0.05). ETA receptor blockade with BQ123 inhibited ET-1-induced increases in splanchnic (64% vs -1%, P<0.05) and renal vascular resistance, while ETB blockade increased basal resistance.

synapsesocial.com/papers/6a8309bf1557c09efd7d5a4fhttps://doi.org/10.1042/cs1040143
Ask AI
Helpful
Bookmark
Share
View Full Paper